In the current study, HXZQ showed anti-CAC effects by improving intestinal microbiota composition, upregulating Nrf2 signaling, and downregulating NF-κB/NLRP3 signaling in AOM/DSS-induced CAC mice. The gene discussed is NLRP3; the disease is infectious otitis media.